Strength
600 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
64980020612
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
ZILEUTONApproval Type
Generic (ANDA)
FDA Application
ANDA204929On Market Since
3/21/2017
Pharmacological Classes
5-Lipoxygenase Inhibitor
5-Lipoxygenase Inhibitors
Decreased Leukotriene Production
Related Drugs
Same classification